NOVN Novan Inc

Novan Inc together with its subsidiaries is a North Carolina based clinical-stage drug development company. It is engaged in the development and commercialization of nitric oxide-based therapies in dermatology.

$1.76  -0.11 (-5.88%)
As of 10/03/2022 16:00:00 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  09/21/2016
Outstanding shares:  21,281,613
Average volume:  135,729
Market cap:   $39,796,616
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Valuation   (See tab for details)
PE ratio:   -1.10
PB ratio:   5.68
PS ratio:   9.79
Return on equity:   -580.07%
Net income %:   -838.95%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy